Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview

Oxycodone - Generic Drug Details

« Back to Dashboard

What are the generic sources for oxycodone and what is the scope of oxycodone freedom to operate?

Oxycodone
is the generic ingredient in six branded drugs marketed by Collegium Pharm Inc, Novel Labs Inc, Mayne Pharma Inc, West-ward Pharms Int, Wes Pharma Inc, Mallinckrodt Inc, Vintage Pharms, Alvogen Malta, Ken Lifescience, Lannett Holdings Inc, Roxane, Lehigh Valley, Actavis Elizabeth, Vistapharm, Amneal Pharms, Wockhardt Bio Ag, Sun Pharm Inds Inc, Aurolife Pharma Llc, Epic Pharma Llc, Purdue Pharma Lp, Avanthi Inc, Ani Pharms Inc, Inspirion Delivery, Egalet Us Inc, Nesher Pharms, Rhodes Pharms, and Corepharma, and is included in thirty-seven NDAs. There are thirty-two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Oxycodone has thirteen patent family members in five countries.

There are seventeen drug master file entries for oxycodone. One supplier is listed for this compound. There are four tentative approvals for this compound.

Summary for Generic Name: oxycodone

Tradenames:6
Patents:32
Applicants:27
NDAs:37
Drug Master File Entries: see list17
Suppliers / Packagers: see list1
Bulk Api Vendors: see list14
Clinical Trials: see list134
Patent Applications: see list14,379
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxycodone at DailyMed

Pharmacology for Ingredient: oxycodone

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

Tentative approvals for OXYCODONE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe80MGTABLET, EXTENDED RELEASE; ORAL
► Subscribe► Subscribe80MGTABLET, EXTENDED RELEASE; ORAL
► Subscribe► Subscribe40MGTABLET, EXTENDED RELEASE; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-005Apr 5, 2010RXYesYes7,674,799► SubscribeYY ► Subscribe
Sun Pharm Inds Inc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL090659-004Nov 6, 2012ABRXNoNo► Subscribe► Subscribe
Egalet Us Inc
OXAYDO
oxycodone hydrochloride
TABLET;ORAL202080-002Jun 17, 2011RXNoNo7,510,726► SubscribeY ► Subscribe
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-006Apr 5, 2010RXYesNo9,073,933► SubscribeY ► Subscribe
Aurolife Pharma Llc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL202160-003Nov 19, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot